Bupe...There it is! Part III - Rollout & Implementation | Palliative Care Educational Series (RECORDING)


Bupe...There it is! Part III - Rollout & Implementation | Palliative Care Educational Series (RECORDING) Banner



Date & Location
Tuesday, August 20, 2024, 12:00 AM - Thursday, August 19, 2027, 11:59 PM, On Demand

Overview
In this recorded Palliative Care Educational Series presentation, Dr. Janet Ho, an expert in palliative care and addiction medicine, discusses the rollout and implementation of buprenorphine treatment for pain management and opioid use disorder. She provides practical guidance on various aspects of buprenorphine prescribing, including low-dose initiation, transitioning from full agonist opioids, managing side effects, and tapering strategies. In addition, the discussion covers case studies, protocols, and best practices for using buprenorphine in different patient scenarios, considering factors such as opioid tolerance, pain levels, and treatment goals. Key topics include the determination of appropriate starting doses, the titration of buprenorphine, the management of precipitated withdrawal, and challenges like skin reactions. Overall, the session aims to equip healthcare providers with the knowledge and skills necessary for safe and effective buprenorphine prescribing, instilling confidence in their prescribing decisions.

Registration
Release Date: August 20, 2024
Expiration Date: August 19, 2027
Estimated Time to Complete: 0.5 hours
Registration Fee: FREE
*Originally recorded 03/13/2024

Credits
AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

Target Audience
Specialties - Family Medicine & Community Health
Professions - Fellow/Resident, Physician

Objectives
At the conclusion of this activity, learners should be able to:

  1. Consider using topical over-the-counter hydrocortisone cream or fluticasone spray to manage skin reactions associated with buprenorphine transdermal patches.
  2. For patients transitioning to hospice care, communicate with the hospice team regarding their comfort level and experience with managing buprenorphine treatment.
  3. When tapering patients off opioids, consider rotating them to buprenorphine as a safer alternative, especially if they exhibit complex persistent opioid dependence or have difficulty tapering off the full agonist opioid.
  4. For patients with opioid use disorder, aim for a buprenorphine dose of at least 16 mg, and preferably 24 mg, before reducing or discontinuing the full agonist opioid.
  5. For patients without opioid use disorder, consider a buprenorphine dose between 6-12 mg as a potential target, adjusting based on pain control and functional improvement.
  6. Develop a detailed treatment plan outlining the buprenorphine initiation and titration schedule, as well as the plan for managing the full agonist opioid and any short-acting opioids for breakthrough pain.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Additional Information

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

Bibliography
View the Course Bibliography  HERE.

For CME general questions, please contact 
     Email: [email protected]